Tasian SK, Gardner RA. CD19-Redirected Chimeric Antigen Receptor-Modified T Cells: a Promising Immunotherapy for Children and Adults with B-Cell Acute Lymphoblastic Leukemia (ALL). Ther Adv Hematol. 2015 Oct;6(5):228-41. - Stand Up To Cancer

Blog

Posted October 3, 2019

Tasian SK, Gardner RA. CD19-Redirected Chimeric Antigen Receptor-Modified T Cells: a Promising Immunotherapy for Children and Adults with B-Cell Acute Lymphoblastic Leukemia (ALL). Ther Adv Hematol. 2015 Oct;6(5):228-41.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.